On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...